Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 281

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer

Open access
Schoppmann, Sebastian F., Bayer, Guenther, Aumayr, Klaus, Taucher, Susanne, Geleff, Silvana, Rudas, Margaretha, Kubista, Ernst, Hausmaninger, Hubert, Samonigg, Hellmut, Gnant, Michael, Jakesz, Raimund, Horvat, Reinhard·2004·Annals of Surgery

Abstract

In Brief Objective: The aim of this study was to investigate the prognostic relevance of lymphangiogenesis and lymphovascular invasion in a large cohort of breast cancer patients. Introduction: Invasion of tumor cells into blood and lymphatic vessels is one of the critical steps for metastasis. The presence or absence of lymph node metastasis is one of the main decision criteria for further therapy. One shortcoming of previous morphologic studies was the lack of specific markers that could exact discriminate between blood and lymphatic vessels. The aim of this study was to evaluate the prognostic relevance of lymphangiogenesis and lymphovascular invasion in breast cancer patients. Methods: We investigated 374 tissue specimens of patients suffering from invasive breast cancer by immunostaining for the lymphatic endothelial specific marker podoplanin. Lymphangiogenesis, quantified by evaluating the lymphatic microvessels density (LMVD), and lymphovascular invasion (LVI) were correlated with various clinical parameters and prognostic relevance. Results: LMVD correlated significantly with LVI (P = 0.001). LVI was associated significantly with a higher risk for developing lymph-node metastasis (P = 0.004). Calculating the prognostic relevance, LVI presented as an independent prognostic parameter for disease free as well as overall survival (P = 0.001, and P = 0.001, respectively). Conclusion: Our data provide evidence that the biologic system of lymphangiogenesis constitutes a potential new target for development of anti-breast cancer therapeutic concepts. Our results further suggest that young, premenopausal patients with low differentiated breast tumors and high LMVD and LVI would, in particular, benefit from lymphangiogenesis-associated therapeutic strategies. The prognostic relevance of lymphangiogenesis and lymphovascular invasion in breast cancer has not been investigated using a specific lymph-endothelial marker. Here we investigated the clinical relevance of lymphangiogenesis and lymphovascular invasion in 374 breast cancer patients using the lymph-endothelial specific marker podoplanin. Our data provide evidence that the system of lymphangiogenesis constitutes a potential new target for the development of anti-breast cancer therapeutic concepts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.sla.0000133355.48672.22

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 281

Metadata

Authors
Schoppmann, S. F., Bayer, G., Aumayr, K., Taucher, S., Geleff, S., Rudas, M., Kubista, E., Hausmaninger, H., Samonigg, H., Gnant, M., Jakesz, R., & Horvat, R.
Venue
Annals of Surgery
Published
2004-08
Volume
240
Issue
2
Pages
306-312
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2115867454
Cited by
281
References
32
FWCI
8.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer. https://app.cochat.ai/papers/10.1097/01.sla.0000133355.48672.22
The paper
Schoppmann, S. F., Bayer, G., Aumayr, K., Taucher, S., Geleff, S., Rudas, M., Kubista, E., Hausmaninger, H., Samonigg, H., Gnant, M., Jakesz, R., & Horvat, R. (2004). Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer. Annals of Surgery. https://doi.org/10.1097/01.sla.0000133355.48672.22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.